Recent advances in therapeutic chalcones

被引：183

作者：

Ni, LM ^{[1
]}

Meng, CQ ^{[1
]}

Sikorski, JA ^{[1
]}

机构：

[1] AtheroGenet Inc, Alpharetta, GA 30004 USA

来源：

EXPERT OPINION ON THERAPEUTIC PATENTS | 2004年 / 14卷 / 12期

关键词：

1,3-diphenyl-2-propen-1-one; alpha; beta-unsaturated ketone; antibacterial; anticancer; anti-infective; anti-inflammatory; antimalarial; antioxidant; chalcone;

D O I：

10.1517/13543776.14.12.1669

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Naturally-occurring and synthetic chalcone compounds have shown promising biological activity and safety profiles and have the potential to be developed as, or more properly, serve as lead compounds for, the discovery of antioxidant, anti-inflammatory, anticancer or anti-infective agents. Mechanisms of the diverse activities observed with chalcone compounds are not well-defined. This review highlights recent developments and patent activities of chalcones with various therapeutic properties.

引用

页码：1669 / 1691

页数：23

共 128 条

[81] Antileishmanial chalcones: Statistical design, synthesis, and three-dimensional quantitative structure-activity relationship analysis [J].